KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Current Liabilities (2016 - 2026)

TherapeuticsMD filings provide 17 years of Total Current Liabilities readings, the most recent being $4.9 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 3.59% to $4.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.9 million, a 3.59% increase, with the full-year FY2025 number at $4.8 million, down 7.38% from a year prior.
  • Total Current Liabilities hit $4.9 million in Q1 2026 for TherapeuticsMD, up from $4.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $264.8 million in Q1 2022 to a low of $4.7 million in Q2 2025.
  • Median Total Current Liabilities over the past 5 years was $6.5 million (2024), compared with a mean of $44.3 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 332.14% in 2022 and later tumbled 92.7% in 2023.
  • TherapeuticsMD's Total Current Liabilities stood at $46.8 million in 2022, then plummeted by 85.37% to $6.9 million in 2023, then dropped by 24.63% to $5.2 million in 2024, then dropped by 7.38% to $4.8 million in 2025, then rose by 2.63% to $4.9 million in 2026.
  • The last three reported values for Total Current Liabilities were $4.9 million (Q1 2026), $4.8 million (Q4 2025), and $4.9 million (Q3 2025) per Business Quant data.